A recent study analyzing 14 pediatric SSc subjects compared to 24 healthy pediatric controls found a significantly elevated proportion of circulating CD4+IL-4+ (TH2) cells in pediatric SSc, and notably 10 of the 14 subjects had later stage disease (>2 years from onset) (58). The gene discussed is IL4; the disease is systemic sclerosis.